Report cover image

Global Lancets Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 02, 2025
Length 198 Pages
SKU # APRC20106379

Description

Summary

According to APO Research, The global Lancets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lancets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Lancets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Lancets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Lancets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Lancets include ARKRAY, Ascensia, B. Braun, BD, Cardinal Health, Greiner Bio One, HemoCue, HTL-STREFA and ICU Medical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lancets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Lancets, also provides the sales of main regions and countries. Of the upcoming market potential for Lancets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lancets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Lancets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Lancets sales, projected growth trends, production technology, application and end-user industry.


Lancets Segment by Company

ARKRAY
Ascensia
B. Braun
BD
Cardinal Health
Greiner Bio One
HemoCue
HTL-STREFA
ICU Medical
I-SENS
Lifescan
Nipro
Owen Mumford
Sarstedt
Terumo
UltiMed
Guangzhou iCare Medical
Roche
Sinocare
Shandong Lianfa
SteriLance Medical
Tianjin Huahong
Abbott
Yicheng
Yuwell

Lancets Segment by Type

Safety Lancets
Ordinary Lancets

Lancets Segment by Application

Children's Fingertip Blood Tests
Glucose Tests
Others

Lancets Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lancets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lancets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lancets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lancets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lancets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lancets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Lancets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Lancets Market Size, 2020 VS 2024 VS 2031
1.3 Global Lancets Market Size Estimates and Forecasts (2020-2031)
1.4 Global Lancets Sales Estimates and Forecasts (2020-2031)
1.5 Global Lancets Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Lancets Market Dynamics
2.1 Lancets Industry Trends
2.2 Lancets Industry Drivers
2.3 Lancets Industry Opportunities and Challenges
2.4 Lancets Industry Restraints
3 Lancets Market by Manufacturers
3.1 Global Lancets Revenue by Manufacturers (2020-2025)
3.2 Global Lancets Sales by Manufacturers (2020-2025)
3.3 Global Lancets Average Sales Price by Manufacturers (2020-2025)
3.4 Global Lancets Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Lancets Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Lancets Manufacturers, Product Type & Application
3.7 Global Lancets Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Lancets Market CR5 and HHI
3.8.2 Global Top 5 and 10 Lancets Players Market Share by Revenue in 2024
3.8.3 2024 Lancets Tier 1, Tier 2, and Tier 3
4 Lancets Market by Type
4.1 Lancets Type Introduction
4.1.1 Safety Lancets
4.1.2 Ordinary Lancets
4.2 Global Lancets Sales by Type
4.2.1 Global Lancets Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Lancets Sales by Type (2020-2031)
4.2.3 Global Lancets Sales Market Share by Type (2020-2031)
4.3 Global Lancets Revenue by Type
4.3.1 Global Lancets Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Lancets Revenue by Type (2020-2031)
4.3.3 Global Lancets Revenue Market Share by Type (2020-2031)
5 Lancets Market by Application
5.1 Lancets Application Introduction
5.1.1 Children's Fingertip Blood Tests
5.1.2 Glucose Tests
5.1.3 Others
5.2 Global Lancets Sales by Application
5.2.1 Global Lancets Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Lancets Sales by Application (2020-2031)
5.2.3 Global Lancets Sales Market Share by Application (2020-2031)
5.3 Global Lancets Revenue by Application
5.3.1 Global Lancets Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Lancets Revenue by Application (2020-2031)
5.3.3 Global Lancets Revenue Market Share by Application (2020-2031)
6 Global Lancets Sales by Region
6.1 Global Lancets Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Lancets Sales by Region (2020-2031)
6.2.1 Global Lancets Sales by Region (2020-2025)
6.2.2 Global Lancets Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Lancets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Lancets Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Lancets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Lancets Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Lancets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Lancets Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Lancets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Lancets Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Lancets Revenue by Region
7.1 Global Lancets Revenue by Region
7.1.1 Global Lancets Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Lancets Revenue by Region (2020-2025)
7.1.3 Global Lancets Revenue by Region (2026-2031)
7.1.4 Global Lancets Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Lancets Revenue (2020-2031)
7.2.2 North America Lancets Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Lancets Revenue (2020-2031)
7.3.2 Europe Lancets Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Lancets Revenue (2020-2031)
7.4.2 Asia-Pacific Lancets Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Lancets Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Lancets Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 ARKRAY
8.1.1 ARKRAY Comapny Information
8.1.2 ARKRAY Business Overview
8.1.3 ARKRAY Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 ARKRAY Lancets Product Portfolio
8.1.5 ARKRAY Recent Developments
8.2 Ascensia
8.2.1 Ascensia Comapny Information
8.2.2 Ascensia Business Overview
8.2.3 Ascensia Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Ascensia Lancets Product Portfolio
8.2.5 Ascensia Recent Developments
8.3 B. Braun
8.3.1 B. Braun Comapny Information
8.3.2 B. Braun Business Overview
8.3.3 B. Braun Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 B. Braun Lancets Product Portfolio
8.3.5 B. Braun Recent Developments
8.4 BD
8.4.1 BD Comapny Information
8.4.2 BD Business Overview
8.4.3 BD Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 BD Lancets Product Portfolio
8.4.5 BD Recent Developments
8.5 Cardinal Health
8.5.1 Cardinal Health Comapny Information
8.5.2 Cardinal Health Business Overview
8.5.3 Cardinal Health Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Cardinal Health Lancets Product Portfolio
8.5.5 Cardinal Health Recent Developments
8.6 Greiner Bio One
8.6.1 Greiner Bio One Comapny Information
8.6.2 Greiner Bio One Business Overview
8.6.3 Greiner Bio One Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Greiner Bio One Lancets Product Portfolio
8.6.5 Greiner Bio One Recent Developments
8.7 HemoCue
8.7.1 HemoCue Comapny Information
8.7.2 HemoCue Business Overview
8.7.3 HemoCue Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 HemoCue Lancets Product Portfolio
8.7.5 HemoCue Recent Developments
8.8 HTL-STREFA
8.8.1 HTL-STREFA Comapny Information
8.8.2 HTL-STREFA Business Overview
8.8.3 HTL-STREFA Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 HTL-STREFA Lancets Product Portfolio
8.8.5 HTL-STREFA Recent Developments
8.9 ICU Medical
8.9.1 ICU Medical Comapny Information
8.9.2 ICU Medical Business Overview
8.9.3 ICU Medical Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 ICU Medical Lancets Product Portfolio
8.9.5 ICU Medical Recent Developments
8.10 I-SENS
8.10.1 I-SENS Comapny Information
8.10.2 I-SENS Business Overview
8.10.3 I-SENS Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 I-SENS Lancets Product Portfolio
8.10.5 I-SENS Recent Developments
8.11 Lifescan
8.11.1 Lifescan Comapny Information
8.11.2 Lifescan Business Overview
8.11.3 Lifescan Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Lifescan Lancets Product Portfolio
8.11.5 Lifescan Recent Developments
8.12 Nipro
8.12.1 Nipro Comapny Information
8.12.2 Nipro Business Overview
8.12.3 Nipro Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Nipro Lancets Product Portfolio
8.12.5 Nipro Recent Developments
8.13 Owen Mumford
8.13.1 Owen Mumford Comapny Information
8.13.2 Owen Mumford Business Overview
8.13.3 Owen Mumford Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Owen Mumford Lancets Product Portfolio
8.13.5 Owen Mumford Recent Developments
8.14 Sarstedt
8.14.1 Sarstedt Comapny Information
8.14.2 Sarstedt Business Overview
8.14.3 Sarstedt Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Sarstedt Lancets Product Portfolio
8.14.5 Sarstedt Recent Developments
8.15 Terumo
8.15.1 Terumo Comapny Information
8.15.2 Terumo Business Overview
8.15.3 Terumo Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Terumo Lancets Product Portfolio
8.15.5 Terumo Recent Developments
8.16 UltiMed
8.16.1 UltiMed Comapny Information
8.16.2 UltiMed Business Overview
8.16.3 UltiMed Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 UltiMed Lancets Product Portfolio
8.16.5 UltiMed Recent Developments
8.17 Guangzhou iCare Medical
8.17.1 Guangzhou iCare Medical Comapny Information
8.17.2 Guangzhou iCare Medical Business Overview
8.17.3 Guangzhou iCare Medical Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.17.4 Guangzhou iCare Medical Lancets Product Portfolio
8.17.5 Guangzhou iCare Medical Recent Developments
8.18 Roche
8.18.1 Roche Comapny Information
8.18.2 Roche Business Overview
8.18.3 Roche Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.18.4 Roche Lancets Product Portfolio
8.18.5 Roche Recent Developments
8.19 Sinocare
8.19.1 Sinocare Comapny Information
8.19.2 Sinocare Business Overview
8.19.3 Sinocare Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.19.4 Sinocare Lancets Product Portfolio
8.19.5 Sinocare Recent Developments
8.20 Shandong Lianfa
8.20.1 Shandong Lianfa Comapny Information
8.20.2 Shandong Lianfa Business Overview
8.20.3 Shandong Lianfa Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.20.4 Shandong Lianfa Lancets Product Portfolio
8.20.5 Shandong Lianfa Recent Developments
8.21 SteriLance Medical
8.21.1 SteriLance Medical Comapny Information
8.21.2 SteriLance Medical Business Overview
8.21.3 SteriLance Medical Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.21.4 SteriLance Medical Lancets Product Portfolio
8.21.5 SteriLance Medical Recent Developments
8.22 Tianjin Huahong
8.22.1 Tianjin Huahong Comapny Information
8.22.2 Tianjin Huahong Business Overview
8.22.3 Tianjin Huahong Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.22.4 Tianjin Huahong Lancets Product Portfolio
8.22.5 Tianjin Huahong Recent Developments
8.23 Abbott
8.23.1 Abbott Comapny Information
8.23.2 Abbott Business Overview
8.23.3 Abbott Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.23.4 Abbott Lancets Product Portfolio
8.23.5 Abbott Recent Developments
8.24 Yicheng
8.24.1 Yicheng Comapny Information
8.24.2 Yicheng Business Overview
8.24.3 Yicheng Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.24.4 Yicheng Lancets Product Portfolio
8.24.5 Yicheng Recent Developments
8.25 Yuwell
8.25.1 Yuwell Comapny Information
8.25.2 Yuwell Business Overview
8.25.3 Yuwell Lancets Sales, Price, Revenue and Gross Margin (2020-2025)
8.25.4 Yuwell Lancets Product Portfolio
8.25.5 Yuwell Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Lancets Value Chain Analysis
9.1.1 Lancets Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Lancets Production Mode & Process
9.2 Lancets Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Lancets Distributors
9.2.3 Lancets Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.